Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 05, 2024

BUY
$0.28 - $1.16 $998 - $4,137
3,567 Added 13.09%
30,816 $10,000
Q1 2024

Apr 30, 2024

BUY
$1.06 - $1.67 $9,869 - $15,549
9,311 Added 51.91%
27,249 $31,000
Q4 2023

Feb 06, 2024

BUY
$1.26 - $1.79 $7,654 - $10,874
6,075 Added 51.21%
17,938 $30,000
Q3 2023

Nov 02, 2023

SELL
$1.61 - $2.54 $11,820 - $18,648
-7,342 Reduced 38.23%
11,863 $21,000
Q1 2023

May 10, 2023

BUY
$1.2 - $2.19 $5,520 - $10,074
4,600 Added 31.5%
19,205 $25,000
Q4 2022

Jan 18, 2023

BUY
$1.63 - $3.52 $23,806 - $51,409
14,605 New
14,605 $0
Q2 2022

Jul 13, 2022

BUY
$2.2 - $4.2 $41,212 - $78,678
18,733 New
18,733 $44,000

Others Institutions Holding DNA

About Ginkgo Bioworks Holdings, Inc.


  • Ticker DNA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 1,287,779,968
  • Market Cap $10.9B
  • Description
  • Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...
More about DNA
Track This Portfolio

Track Private Advisor Group, LLC Portfolio

Follow Private Advisor Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Private Advisor Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Private Advisor Group, LLC with notifications on news.